Bridge City Capital LLC bought a new position in Hawkins, Inc. (NASDAQ:HWKN – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,354 shares of the specialty chemicals company’s stock, valued at approximately $1,755,000. Bridge City Capital LLC owned approximately 0.06% of Hawkins as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. NewEdge Wealth LLC bought a new position in shares of Hawkins in the third quarter worth approximately $935,000. Envestnet Asset Management Inc. lifted its stake in shares of Hawkins by 74.6% in the third quarter. Envestnet Asset Management Inc. now owns 24,050 shares of the specialty chemicals company’s stock worth $4,394,000 after buying an additional 10,279 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Hawkins by 159.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 34,554 shares of the specialty chemicals company’s stock worth $5,020,000 after buying an additional 21,216 shares in the last quarter. Ascent Group LLC bought a new position in shares of Hawkins in the fourth quarter worth approximately $3,454,000. Finally, Aptus Capital Advisors LLC lifted its stake in shares of Hawkins by 15.2% in the third quarter. Aptus Capital Advisors LLC now owns 105,040 shares of the specialty chemicals company’s stock worth $19,193,000 after buying an additional 13,845 shares in the last quarter. Institutional investors own 69.71% of the company’s stock.
Analyst Upgrades and Downgrades
HWKN has been the topic of several analyst reports. BWS Financial reiterated a “buy” rating and issued a $200.00 target price on shares of Hawkins in a research note on Monday, March 23rd. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, June 8th. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $200.00.
Hawkins Stock Up 0.9%
Shares of Hawkins stock opened at $158.34 on Friday. The company has a market cap of $3.30 billion, a price-to-earnings ratio of 40.50, a price-to-earnings-growth ratio of 2.85 and a beta of 0.76. The company’s 50 day moving average is $157.54 and its 200 day moving average is $149.07. Hawkins, Inc. has a twelve month low of $117.98 and a twelve month high of $186.15. The company has a quick ratio of 1.46, a current ratio of 2.21 and a debt-to-equity ratio of 0.46.
Hawkins (NASDAQ:HWKN – Get Free Report) last issued its quarterly earnings data on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The company had revenue of $265.91 million for the quarter, compared to the consensus estimate of $255.28 million. Hawkins had a net margin of 7.53% and a return on equity of 16.08%. Research analysts anticipate that Hawkins, Inc. will post 4.27 EPS for the current year.
Hawkins Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were given a dividend of $0.19 per share. The ex-dividend date was Friday, May 29th. This represents a $0.76 dividend on an annualized basis and a yield of 0.5%. Hawkins’s dividend payout ratio is 19.44%.
Hawkins Company Profile
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
See Also
- Five stocks we like better than Hawkins
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
